Allophylus cominia
Allophylus cominia · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Allophylus cominia is a significant medicinal shrub known for its diverse phytochemical profile and therapeutic potential. Researchers frequently utilize various extracts from its leaves and stems to isolate bioactive compounds. These preparations are studied extensively for their ability to exhibit antioxidant and antimicrobial properties. By employing different solvent extraction methods, scientists aim to harness the plant's full pharmacological spectrum. Consequently, this species remains a subject of great interest in the development of natural therapeutic agents.
- Synonyms
- Rhus Cominia · Ornitrophe Cominia · 1 more
- Common names
- Not available
- Family
- Sapindaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Allophylus cominia is a versatile plant recognized by a diverse array of regional names. It is frequently referred to by the common name Cafe marron in certain areas. Depending on the local dialect, many people also simply call it Caja or Caja comun. In other parts of its habitat, it is known specifically as Caja yanilla. Finally, the species is often identified as Palo de caja, highlighting its various cultural connections.
Sources: Catalogue of Life (COL)
Synonyms
Allophylus cominia is a botanical species that has been documented under several different scientific names throughout history. In various taxonomic records, the plant is recognized by the synonym Ornitrophe cominia. It has also been formally referred to as Rhus cominia in older botanical literature. Furthermore, the name Schmidelia cominia serves as another established synonym for this specific taxon. Understanding these varying nomenclatures is essential for researchers navigating the complex history of its classification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Allophylus cominia is a distinctive member of the kingdom Plantae. This species is classified under the class Equisetopsida and belongs to the order Sapindales. Within this botanical order, it is a representative of the Sapindaceae family. It is further categorized into the specific genus Allophylus. Ultimately, these taxonomic relationships define the biological identity of this unique plant.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Sapindaceae |
| Genus | Allophylus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Allophylus cominia exhibits a broad and diverse geographic range that stretches across multiple regions. In North America, the species is widely distributed throughout various parts of Mexico, including the central, gulf, southeast, and southwest territories. Its presence also extends into the Caribbean, where it can be found throughout the Bahamas. Furthermore, the plant establishes itself across significant portions of Southern America. This widespread distribution highlights the plant's ability to thrive in various tropical and subtropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Allophylus cominia grows in the form of a sturdy tree. This species is naturally self-supporting, allowing it to maintain a stable structure as it matures.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Allophylus cominia shows significant potential in the treatment and management of type 2 diabetes mellitus (T2-DM) due to its bioactive components. Research indicates that its flavonoids and pheophytins enhance insulin activity by increasing glucose uptake in HepG2 and L6 cells. Furthermore, these extracts have been shown to inhibit PTP1B and DPPIV enzyme activities, which are key targets in diabetes therapy. The plant also demonstrates an ability to decrease fat accumulation in 3T3-L1 adipocytes by reducing lipid droplets. Consequently, A. cominia serves as a promising candidate for developing new drugs to address T2-DM.
Preparations
Allophylus cominia is prepared as extracts to investigate its potential pharmacological properties in treating type 2 diabetes mellitus. These characterized extracts, specifically containing flavonoids and pheophytins, were tested for their ability to enhance glucose uptake in various cell lines. Research demonstrated that the flavonoid mixture from the plant significantly decreased the insulin EC50 values in HepG2 and L6 cells. Furthermore, the extracts were found to decrease fat accumulation in 3T3-L1 adipocytes by reducing lipid droplets. These findings highlight how the processed extracts of A. cominia serve as a possible source for new anti-diabetic drugs.